Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,214 total articles

XFLT Urges Shareholders to Approve the King Street Sub-Adviser and Effect Liquidity Plan Ahead of August 6th Meeting

XFLT Urges Shareholders to Approve the King Street Sub-Adviser and Effect Liquidity Plan Ahead of August 6th Meeting

XAI Floating Rate & Alternative Income Trust (XFLT) is urging shareholders to vote in favor of appointing King Street Capital Management's subsidiary as long-term sub-adviser and approve a liquidity plan involving tender offers to repurchase 25% of fund shares. Key proxy advisory firms and investment research services recommend voting for the propo…

FingerMotion Announces Leadership Change

FingerMotion Announces Leadership Change

FingerMotion, Inc., a Nasdaq-listed mobile services and technology company, announced a leadership change with the appointment of Jolie Kahn as CEO, succeeding Martin Shen. Kahn brings extensive experience in corporate finance, public company management, and digital asset-related businesses. The company aims to leverage its growing user base and in…

Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

Charlton Aria Acquisition Corporation, a Cayman Islands exempted blank check company listed on Nasdaq, announced a three-month extension until October 25, 2026, for completing its initial business combination. This marks the second extension after the Sponsor deposited $850,000 into the trust account, allowing more time to identify and consummate a…

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

Acrivon Therapeutics announced that its investigational drug ACR-2316, a novel WEE1/PKMYT1 inhibitor, has progressed into the randomized dose expansion phase of its ongoing Phase 1/2 clinical trial. The advancement follows a favorable safety profile and evidence of durable clinical activity, including tumor shrinkage and partial responses in heavil…

Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway

Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway

Splash Beverage Group has entered a strategic collaboration with Lupvindol Biosciences Ltd. to advance CannEpil® as a potential FDA-regulated veterinary pharmaceutical product focused initially on companion-animal oncology and chronic pain management. The program aims to navigate the FDA veterinary drug approval pathway to achieve conditional appro…

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

Vivos Therapeutics announced the issuance of a new US patent (No. 12,697,190) that broadens protection for its Vivos CARE oral medical devices, designed to treat obstructive sleep apnea (OSA). This continuation patent complements their earlier patent, enhancing protection against competitors. With FDA 510(k) clearances for treating severe OSA in ad…

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

SciSparc Ltd., through its subsidiary NeuroThera Labs, has launched a Phase IIb clinical trial of SCI-110, a cannabinoid-based drug candidate for Tourette Syndrome treatment, at Yale Child Study Center in the USA. This multinational trial also includes sites in Germany and Israel and builds on positive Phase IIa results, aiming to advance regulator…

Ocean Power Technologies Selected for Participation in $40 Million U.S. Navy Project for Autonomous Ocean Mapping

Ocean Power Technologies Selected for Participation in $40 Million U.S. Navy Project for Autonomous Ocean Mapping

Ocean Power Technologies, Inc. (NYSE American: OPTT) has been chosen as one of six potential awardees for a $40 million multiple-award contract by the U.S. Naval Oceanographic Office to provide high-resolution ocean-floor mapping using long-endurance unmanned surface vehicles. The contract spans two years with task orders competed among awardees an…

Alpha Modus Targets Approximately $8 Million in Revenue Under Multi-Year National Consumer Market Research Services Agreement

Alpha Modus Targets Approximately $8 Million in Revenue Under Multi-Year National Consumer Market Research Services Agreement

Alpha Modus Holdings, an AI technology company specializing in consumer engagement and data analytics, announced a multi-year services agreement with a national market research firm expected to generate approximately $8 million in revenue over multiple years. This contract marks the company's entry into a new enterprise services vertical beyond its…

Terra Innovatum Added to Solactive Global Uranium & Nuclear Components Total Return Index, the Benchmark Tracked by the Global X Uranium ETF (URA)

Terra Innovatum Added to Solactive Global Uranium & Nuclear Components Total Return Index, the Benchmark Tracked by the Global X Uranium ETF (URA)

Terra Innovatum Global N.V., a Nasdaq-listed micro-modular reactor developer, has been added to the Solactive Global Uranium & Nuclear Components Total Return Index, the benchmark tracked by the Global X Uranium ETF (URA). This inclusion expands Terra Innovatum’s visibility to institutional and passive investors seeking exposure to the uranium and …

One Stop Systems Reports Q2 2026 Results

One Stop Systems Reports Q2 2026 Results

One Stop Systems reported a 62.3% year-over-year increase in Q2 2026 revenue to $9.3 million and recorded its highest quarterly bookings of $15.1 million, reflecting strong demand in rugged enterprise-class edge computing solutions. Driven by diverse defense and commercial customers, including a significant U.S. Department of Defense contract, the …

Karat Packaging Board Increases Quarterly Cash Dividend

Karat Packaging Board Increases Quarterly Cash Dividend

Karat Packaging Inc., a U.S.-based manufacturer and distributor of disposable foodservice products, announced a 4.4% increase in its quarterly cash dividend to $0.47 per share, payable August 28, 2026. This dividend hike reflects the company's strong financial position and shareholder returns focus.